Related Experiment Video
Updated: Jan 23, 2026

In vivo Imaging Method to Distinguish Acute and Chronic Inflammation
Published on: August 16, 2013
Cognitive Decline in Chronic Migraine with Nonsteroid Anti-inflammation Drug Overuse: A Cross-Sectional Study
Xiaoying Cai1,2, Xiaotian Xu2, Aiwu Zhang2
1Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan 2nd Road, Guangzhou 510080, China.
Background:
Chronic migraine with medication overuse headache (CM-MOH) is the most common type of chronic migraine, and it increases risk of stroke and white matter lesions. These pathologic changes could induce cognitive decline. However, the alteration of cognitive function in CM-MOH patients is not established. Therefore, we took this study to reveal the cognitive performances in CM-MOH.
Methods:
This cross-sectional study was conducted between December 2015 and January 2017. Patients were divided into CM-MOH, CMwoMOH (chronic migraine without medication overuse), and MO (migraine without aura) groups. Cognitive function was assessed in all cases during interictal periods using Addenbrooke's Cognitive Examination Test (ACE-R), Trail Making Test A/B (TMT A/B), and Digit Symbol Test (DST). Detailed headache characteristics and evaluation of anxiety, depression, and living and sleep quality were collected.
Results:
116 patients were included in this study. There were 21 CM-MOHs, 20 CMwoMOHs, 35 MOs, and 40 controls. Age and education were the independent risk factors of cognitive decline (P < 0.05). After adjusting, the risk of cognitive decline was higher in CM compared with control in ACE-R score and language fluency (P < 0.05). In addition, CM-MOH sufferers were in higher risk of memory and executive dysfunction (P < 0.05). The cognitive function had no difference between CM-MOH and CMwoMOH (P > 0.05). Meanwhile, CM-MOH got significantly higher scores than MO in anxiety and depression, with poorer performances in sleep and life quality (P < 0.05).
Conclusion:
The risk of cognitive decline increased in chronic migraine patients. Nonsteroid anti-inflammatory drugs overuse had no influence on cognitive performances among chronic migraine sufferers.
Insights
Chronic migraine patients face increased cognitive decline risk. Medication overuse did not impact cognitive performance in chronic migraine sufferers, but anxiety and depression were higher in those with medication overuse headaches.
Area of Science:
- Neurology
- Neuroscience
- Cognitive Science
Background:
- Chronic migraine with medication overuse headache (CM-MOH) is a prevalent form of chronic migraine.
- CM-MOH is associated with increased risks of stroke and white matter lesions, potentially leading to cognitive decline.
- The precise impact of CM-MOH on cognitive function remains incompletely understood.
Purpose of the Study:
- To investigate and define the cognitive performance alterations in patients with CM-MOH.
- To compare cognitive functions across different migraine subgroups and healthy controls.
Main Methods:
- A cross-sectional study involving 116 participants, including CM-MOH, chronic migraine without medication overuse (CMwoMOH), migraine without aura (MO), and control groups.
- Cognitive function assessed using Addenbrooke's Cognitive Examination Test (ACE-R), Trail Making Test A/B (TMT A/B), and Digit Symbol Test (DST) during interictal periods.
- Data collection included headache characteristics, anxiety, depression, and sleep and life quality assessments.
Main Results:
- Chronic migraine (CM) patients exhibited a higher risk of cognitive decline compared to controls, particularly in ACE-R scores and language fluency.
- Patients with CM-MOH showed increased risks of memory and executive dysfunction.
- No significant cognitive differences were found between CM-MOH and CMwoMOH groups; however, CM-MOH patients reported higher anxiety, depression, and poorer sleep and life quality compared to MO patients.
Conclusions:
- Cognitive decline is a significant risk associated with chronic migraine.
- Medication overuse, specifically nonsteroidal anti-inflammatory drugs, did not independently influence cognitive performance in chronic migraine sufferers.
- While medication overuse itself may not directly impair cognition in CM, the associated psychological distress and quality of life factors warrant attention.
Related Concept Videos
Cross-Sectional Research
Profile Leveling and Cross Sections
Spinal Cord: Cross-sectional Anatomy
Gray Matter and its Components
Central to the gray matter is...
Inflammation
Magnetic Declination
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

